Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arca Investigational Site #127
San Nicolás de los Arroyos, Buenos Aires, Argentina
- Arca Investigational Site #130
Rosario, Santa Fe Province, Argentina
- Arca Investigational Site #112
Rosario, Sante Fe, Argentina
- Arca Investigational Site #111
Buenos Aires, Argentina
- Arca Investigational Site #115
CABA, Argentina
- Arca Investigational Site #126
Córdoba, Argentina
- Arca Investigational Site #106
San Miguel de Tucumán, Argentina
- Arca Investigational Site #129
San Miguel de Tucumán, Argentina
- Arca Investigational Site #125
Campo Grande, Mato Grosso do Sul, Brazil
- Arca Investigational Site #124
Bragança Paulista, São Paulo, Brazil
- Arca Investigational Site #122
São José do Rio Preto, São Paulo, Brazil
- Arca Investigational Site #123
Porto Alegre, Brazil
- Arca Investigational Site #121
São Paulo, Brazil
- Arca Investigational Site #119
Fairhope, Alabama, United States
- Arca Investigational Site #118
Phoenix, Arizona, United States
- Arca Investigational Site #120
Tucson, Arizona, United States
- Arca Investigational Site #104
Aurora, Colorado, United States
- Arca Investigational Site #117
Denver, Colorado, United States
- Arca Investigational Site #101
Jacksonville, Florida, United States
- Arca Investigational Site #128
Evanston, Illinois, United States
- Arca Investigational Site #113
New Orleans, Louisiana, United States
- Arca Investigational Site #105
Falls Church, Virginia, United States
- Arca Investigational Site #114
Richmond, Virginia, United States
- Arca Investigational Site #103
Tacoma, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Dec 2020
- Primary completion
- 6 Dec 2021
- Completion
- 7 Mar 2022
- Last update posted
- 21 Feb 2023
- Registered enrollment
- 160
- Registry id
- NCT04655586
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.